US EditionCE mark approval for Biosensors’ Imperia THV delivery system - Cardiovascular News
Summary by Cardiovascular News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
CE mark approval for Biosensors’ Imperia THV delivery system - Cardiovascular News
Biosensors International has received CE mark certification for the Imperia delivery system under the EU Medical Device Regulation (MDR). The Imperia delivery system is part of the Allegra transcatheter heart valve (THV) system and is intended for the transfemoral implantation of the already CE-marked Allegra THV, indicated for the treatment of severe aortic stenosis. The new delivery system emphasises ease of use while maintaining maximum safet…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
